Trump's efforts to lower drug prices are advancing, with the latest initiative aimed at supporting in vitro fertilization
U.S. President Trump announced two initiatives that he said would make in vitro fertilization more accessible and affordable, part of his broader agenda to expand reproductive benefits and lower drug prices.
Trump claimed that an agreement had been reached with Merck KGaA to reduce the prices of fertility drugs (in the U.S. market), and the company would receive tariff relief.
Trump announced that his administration had reached an agreement with the pharmaceutical company EMD Serono to lower the costs of certain fertility drugs
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments